Categories AlphaGraphs, Consumer, Earnings, Other Industries

Infographic: The JM Smucker Company Q4 2021 earnings

JM Smucker Company (NYSE: SJM) reported fourth-quarter financial results before the opening bell on Thursday.

The company reported an 8% decrease in Q4 net sales to $1.92 billion, which was higher than the Wall Street consensus.

The net earnings were $147 million or $1.35 per share compared to $226.3 or $1.98 per share of the same quarter in the previous year.

The adjusted earnings was reported at $1.89, a decrease of 26%.

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Viewing Highlight